NewGenIvf (NIVF) Invested Capital (2022 - 2025)

NewGenIvf (NIVF) has 4 years of Invested Capital data on file, last reported at $26.9 million in Q4 2025.

• In Q4 2025, Invested Capital rose 2680.35% year-over-year to $26.9 million; the TTM figure through Dec 2025 stood at $26.9 million (up 2680.35% YoY), while the FY2025 annual figure was $26.9 million, up 2680.35% from the prior year.
• Invested Capital grew to $26.9 million in Q4 2025, from -$1.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $26.9 million in Q4 2025 and bottomed at -$1.0 million in Q4 2024.
• A 4-year average of $7.5 million and a median of $2.0 million in 2022 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2024 — Invested Capital plunged 129.18% — and 2025, when it surged 2680.35%.
• Year by year, Invested Capital stood at $527521.0 in 2022, then surged by 577.07% to $3.6 million in 2023, then plunged by 129.18% to -$1.0 million in 2024, then surged by 2680.35% to $26.9 million in 2025.
• The last three Invested Capital figures came in at $26.9 million (Q4 2025), -$1.0 million (Q4 2024), and $3.6 million (Q4 2023), per Business Quant data.

Peer Comparison